Sunday, June 30, 2013

Cheap Indian Drugs Spur Rare Congressional Bipartisanship

It looks as if we have a sighting of that rare Washington, D.C., unicorn: bipartisan agreement in the halls of Congress. Democrats and Republicans have united in defense of Big Pharma and are lobbying the Obama administration and State Department to pressure India's generic-drug policies.

In this video, health-care analyst David Williamson discusses what has Congress riled up, the importance of India as a growth driver for the pharma industry, and whether investors need to start taking precautions with their portfolios.

Rising health-care costs continue to be a hotly debated topic, and even legendary investor Warren Buffett called this trend "the tapeworm that's eating at American competitiveness." To learn more about what's happening to the health care system -- and how to potentially profit from this trend -- click here for free, immediate access.

Follow David on Twitter: @MotleyDavid.

No comments:

Post a Comment